Biosafety AsahiKASEI joint seminar

Joint seminar between Vironova Biosafety and AsahiKASEI on virus safety and filtration  


Vironova in panel discussion on cell and gene therapy

This week Vironova is participating in a panel discussion at the Cell and Gene Therapy Bioprocessing and Commercialization conference in Boston, represented by Nina Forsberg, Marketing Director.


New ASTM standard approved

Vironova scientists continue to influence the field - new standard approved In the spring of 2017 Vironova, being identified as leading experts in the characterization of liposomes, was invited by the FDA to participate in developing a standard for...


Vironova have received a certificate of GMP compliance of a manufacturer from the Swedish Medical Products Agency

Vironova has received the world’s first and only GMP certification for Electron Microscope Lab from Swedish Medical Products Agency


Latest webinar now available on-demand

The Vironova team of Josefina Nilsson, Head EM services and Martin Ryner, Manager Strategic Development presented a webinar on the 11th April with over 200 people participating.


Biosafety passed SWEDAC inspection

Vironova Biosafety specializes in performing viral clearance studies for biological drugs and is the only Nordic CRO that conducts these studies in BSLII and BSLIII certified cell and virus laboratories in compliance with good laboratory practices...


Two Vironova patent applications have successfully passed the international phase

Two Vironova patent applications have successfully passed the international phase We’re very pleased to announce that our patent "A method for quantification of purity of sub-visible particle samples" has now passed the PCT (international patent...


MiniTEM contributes to the success of our customers – good testimonials at the Cell & Gene therapy conference in Amsterdam.

The event at Cell & Gene Therapy in Amsterdam this week was a successful showcase for MiniTEM. Apart from our own activities at our booth and a presentation in the main program we also received an excellent testimonial from Hanna Lesch, Research and...


Vironova’s CEO, Mohammed Homman, has been elected onto IVA’s Business Executives Council (Näringslivsrådet)

The Royal Swedish Academy of Engineering Sciences (Kungl. Ingenjörsvetenskapsakademien, IVA), Business Executives Council met on the 29th November for their annual meeting at which we are proud to announce that Vironova’s CEO, Mohammed Homman was...


Vironova awarded funding to advance expertise in AI

We are proud to announce that Vironova has been awarded funding for a two-year research project entitled “Interactive visualization tools for verification and improvement of deep neural network predictions.” The project will stretch over two years...